# Spyre Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Oct 9, 2026

- Company: [Spyre Therapeutics, Inc.](/companies/syre.md) (CIK 1636282)
- Form: SCHEDULE 13D/A
- Filed: 2026-10-09
- Accepted by EDGAR: Oct 9, 2026, 17:00 ET
- Period: not reported
- Accession: 0001104659-26-115087
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1636282/000110465926115087/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1636282/000110465926115087/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1636282/000110465926115087/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Oct 9, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-115087. Last ingested by Listed: Nov 3, 2026, 18:46 ET. No prices; not investment advice.